Lupus Nephritis Clinical Trials in Chicago, Illinois
7 recruitingChicago, Illinois
Showing 1–7 of 7 trials
Recruiting
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus
Lupus Research Alliance3,500 enrolled25 locationsNCT05934149
Recruiting
Phase 1Phase 2
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio28 enrolled23 locationsNCT06121297
Recruiting
Phase 2
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
Lupus Nephritis
Children's Hospital Medical Center, Cincinnati105 enrolled19 locationsNCT05538208
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc.96 enrolled16 locationsNCT06557265
Recruiting
Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Lupus Erythematosus, SystemicLupus Nephritis
Novartis Pharmaceuticals179 enrolled93 locationsNCT06581198
Recruiting
Phase 2
VIBRANT: VIB4920 for Active Lupus Nephritis
Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID)74 enrolled17 locationsNCT05201469
Recruiting
Phase 1
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
SLE (Systemic Lupus)Diffuse Cutaneous Systemic SclerosisSystemic Sclerosis+4 more
CRISPR Therapeutics80 enrolled8 locationsNCT06925542